<p>(a) Luciferase activities following infection of adenovirus vectors <i>in vitro</i>. The AsPC-1, PSN-1, SKOV3 and MKN45 cells were infected with adenovirus vectors (AdΔCAR-LucEGFP-PFW, AdΔCAR-LucEGFP-SYE, AdΔCAR-LucEGFP or Ad-LucEGFP), and 24 h later the luciferase activities were measured. (b) Competitive inhibition of transduction of the adenovirus vector with selected peptide. Transduction efficiencies of AdΔCAR-LucEGFP-PFW in AsPC-1 cells were evaluated at moi 30 in the presence of the cognate or a control unrelated peptide at 0.2–1.5 mmol/L. The data are expressed as the relative luciferase activity (luciferase activity in the presence of peptide/that in the absence of peptide). Control peptide: AQGQWAL.</p
<p>Peptides were screened for inhibition of the pseudotyped reporter viruses RVF-VSV-luc (A and C) a...
Adenovirus serotype 5 remains one of the most promising vectors for delivering genetic material to c...
We have previously developed a novel adenovirus vector (Adv) that targeted tumor tissues/vasculature...
<p>(a) Infectivity of AsPC-1 peritoneal tumors with AdΔCAR-LucEGFP-PFW. The various amounts (1, 3, 1...
<p>(a–d) Cell lines were infected with Ad5luc1, Ad5/3luc1, and Ad5lucRGD. Luciferase activity is exp...
<p>The luciferase reporter virus TB40-BAC4-IE-Gluc was preincubated with 40mer peptides derived from...
The targeting of gene transfer at the cell-entry level is one of the most attractive challenges in v...
<p>(a) Infectivity of organs with adenovirus vectors. The mice were injected intraperitoneally with ...
The targeting of gene transfer at the cell-entry level is one of the most attractive challenges in v...
<p>(A) Relative luciferase activity in PPT/HeLa cells incubated with conjugated or unconjugated ASPN...
<p>A: Primary PymT breast cancer cells were transduced by recombinant AAV-2 luciferase reporter gene...
Due to the fundamental progress in elucidating the molecular mechanisms of human diseases and the ar...
<p>(<b>A</b>) Schematic representation of the Ad5 precursor pVII, mature VII, propeptide and 1-24Gal...
<p>AAV luciferase vectors displaying selected peptides or controls (wild-type or VRRPRFW) were injec...
Targeting viral vectors to certain tissues in vivo has been a major challenge in gene therapy. Cell ...
<p>Peptides were screened for inhibition of the pseudotyped reporter viruses RVF-VSV-luc (A and C) a...
Adenovirus serotype 5 remains one of the most promising vectors for delivering genetic material to c...
We have previously developed a novel adenovirus vector (Adv) that targeted tumor tissues/vasculature...
<p>(a) Infectivity of AsPC-1 peritoneal tumors with AdΔCAR-LucEGFP-PFW. The various amounts (1, 3, 1...
<p>(a–d) Cell lines were infected with Ad5luc1, Ad5/3luc1, and Ad5lucRGD. Luciferase activity is exp...
<p>The luciferase reporter virus TB40-BAC4-IE-Gluc was preincubated with 40mer peptides derived from...
The targeting of gene transfer at the cell-entry level is one of the most attractive challenges in v...
<p>(a) Infectivity of organs with adenovirus vectors. The mice were injected intraperitoneally with ...
The targeting of gene transfer at the cell-entry level is one of the most attractive challenges in v...
<p>(A) Relative luciferase activity in PPT/HeLa cells incubated with conjugated or unconjugated ASPN...
<p>A: Primary PymT breast cancer cells were transduced by recombinant AAV-2 luciferase reporter gene...
Due to the fundamental progress in elucidating the molecular mechanisms of human diseases and the ar...
<p>(<b>A</b>) Schematic representation of the Ad5 precursor pVII, mature VII, propeptide and 1-24Gal...
<p>AAV luciferase vectors displaying selected peptides or controls (wild-type or VRRPRFW) were injec...
Targeting viral vectors to certain tissues in vivo has been a major challenge in gene therapy. Cell ...
<p>Peptides were screened for inhibition of the pseudotyped reporter viruses RVF-VSV-luc (A and C) a...
Adenovirus serotype 5 remains one of the most promising vectors for delivering genetic material to c...
We have previously developed a novel adenovirus vector (Adv) that targeted tumor tissues/vasculature...